William J. CALLAHAN

Person

Thousand Oaks, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-TNF alpha antibody formulations
- Patent number 12,247,071
- Issue date Mar 11, 2025
- Amgen Inc.
- William J. Callahan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGFR-Fc fusion protein formulations
- Patent number 12,156,900
- Issue date Dec 3, 2024
- Amgen Inc.
- Yael Wexler-Cohen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Reduced viscosity protein pharmaceutical formulations
- Patent number 11,459,401
- Issue date Oct 4, 2022
- Amgen Inc.
- Alona Teran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable compositions of pegylated carfilzomib compounds
- Patent number 11,241,502
- Issue date Feb 8, 2022
- Amgen Inc.
- Alona Teran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lyophilized therapeutic peptibody formulations
- Patent number 10,166,189
- Issue date Jan 1, 2019
- Amgen Inc.
- William J. Callahan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lyophilized therapeutic peptibody formulations
- Patent number 9,283,260
- Issue date Mar 15, 2016
- Amgen Inc.
- William J. Callahan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
VEGFR-FC FUSION PROTEIN FORMULATIONS
- Publication number 20250082726
- Publication date Mar 13, 2025
- Amgen Inc.
- Yael WEXLER-COHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TNF ALPHA ANTIBODY FORMULATIONS
- Publication number 20230151086
- Publication date May 18, 2023
- Amgen Inc.
- William J. CALLAHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
- Publication number 20230048560
- Publication date Feb 16, 2023
- Amgen Inc.
- Alona TERAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR MAKING STABLE PROTEIN COMPOSITIONS
- Publication number 20210163531
- Publication date Jun 3, 2021
- Amgen Inc.
- William Callahan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGFR-FC FUSION PROTEIN FORMULATIONS
- Publication number 20200338164
- Publication date Oct 29, 2020
- Amgen Inc.
- Yael WEXLER-COHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TNF ALPHA ANTIBODY FORMULATIONS
- Publication number 20200087390
- Publication date Mar 19, 2020
- Amgen Inc.
- William J. CALLAHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REDUCED VISCOSITY PROTEIN PHARMACEUTICAL FORMULATIONS
- Publication number 20200024363
- Publication date Jan 23, 2020
- Amgen Inc.
- Alona Teran
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
- Publication number 20190142957
- Publication date May 16, 2019
- Amgen Inc.
- Alona TERAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED THERAPEUTIC PEPTIBODY FORMULATIONS
- Publication number 20160143852
- Publication date May 26, 2016
- Amgen Inc.
- William J. CALLAHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Lyophilized therapeutic peptibody Formulations
- Publication number 20090258017
- Publication date Oct 15, 2009
- William J. Callahan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

William J. CALLAHAN

Person

Patents Grantslast 30 patents

Anti-TNF alpha antibody formulations

VEGFR-Fc fusion protein formulations

Reduced viscosity protein pharmaceutical formulations

Stable compositions of pegylated carfilzomib compounds

Lyophilized therapeutic peptibody formulations

Lyophilized therapeutic peptibody formulations

Patents Applicationslast 30 patents

VEGFR-FC FUSION PROTEIN FORMULATIONS

ANTI-TNF ALPHA ANTIBODY FORMULATIONS

STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS

METHODS FOR MAKING STABLE PROTEIN COMPOSITIONS

VEGFR-FC FUSION PROTEIN FORMULATIONS

ANTI-TNF ALPHA ANTIBODY FORMULATIONS

REDUCED VISCOSITY PROTEIN PHARMACEUTICAL FORMULATIONS

STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS

LYOPHILIZED THERAPEUTIC PEPTIBODY FORMULATIONS

Lyophilized therapeutic peptibody Formulations